a |
Fig. 1B, ipsilateral rotations at 12 weeks: GDNF (1 µg) vs PBS at 12 weeks | Normal distribution | One-way ANOVA, Tukey | 0.006 |
b |
Fig. 1B, ipsilateral rotations at 12 weeks: GDNF (1 µg) + CDNF (1 µg) vs PBS at 12 weeks | Normal distribution | One-way ANOVA, Tukey | 0.0306 |
c |
Fig. 1B, ipsilateral rotations at 12 weeks, GDNF (1 µg) + CDNF (2.5 µg) vs PBS at 12 weeks | Normal distribution | One-way ANOVA, Tukey | 0.001 |
d |
Fig. 1B, ipsilateral rotations at 10 weeks: CDNF (2.5 µg) vs PBS at 12 weeks | Normal distribution | One-way ANOVA, Tukey | 0.029 |
e |
Fig. 1D, ipsilateral rotations at 12 weeks, GDNF (2.5 µg) vs PBS at 12 weeks after lesion | Normal distribution | One-way ANOVA, Tukey | 0.0104 |
f |
Fig. 1D, ipsilateral rotations at 12 weeks, GDNF (2.5 µg) + CDNF (2.5 µg) vs PBS at 12 weeks after lesion | Normal distribution | One-way ANOVA, Tukey | 0.0113 |
g |
Fig. 2A, TH cell numbers, GDNF (1 µg) + GDNF (2.5 µg) vs VEH | Normal distribution | One-way ANOVA, Tukey | 0.046 |
h |
Fig. 2B, Nissl-positive cells, All NTF-treated groups differed from VEH | Normal distribution | One-way ANOVA, Tukey | 0.0001 |
i |
Fig. 4C, OD of pS6 staining in STR. CDNF (2.5 µg) vs GDNF (1 µg) | Normal distribution | One-way ANOVA, Tukey | 0.0184 |
j |
Fig. 4D, pERK-positive cells in STR. All NTF-treated groups differed from VEH | Normal distribution | One-way ANOVA, Tukey | 0.0077 |
k |
Fig. 5A, level of ATF6 expression in DA neuron cultures, CDNF (100 ng/ml) vs control, no factor | Normal distribution | One-way ANOVA, Tukey | 0.04 |
l |
Fig. 5A, level of ATF6 expression in DA neuron cultures, combination [CDNF (100 ng/ml) + GDNF (50 ng/ml)] vs control | Normal distribution | One-way ANOVA, Tukey | 0.0102 |
m |
Fig. 5E, GRP78 expression, CDNF (2.5 µg) vs GDNF (1 µg) | Normal distribution | One-way ANOVA, Tukey | 0.014 |